Xtant Medical Holdings, Inc. (XTNT)
| Market Cap | 109.25M |
| Revenue (ttm) | 55.55M |
| Net Income (ttm) | -2.83M |
| Shares Out | 86.71M |
| EPS (ttm) | -0.05 |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 85,419 |
| Open | 1.24 |
| Previous Close | 1.26 |
| Day's Range | 1.18 - 1.26 |
| 52-Week Range | 1.03 - 6.58 |
| Beta | 1.45 |
| Analysts | Hold |
| Price Target | 1.00 (-15.3%) |
| Est. Earnings Date | Oct 28, 2021 |
About XTNT
Xtant Medical Holdings, Inc. develops, manufactures, and markets regenerative medicine products and medical devices for orthopedic and neurological surgeons in the United States and internationally. Its biomaterial products include OsteoSponge that provides a natural scaffold for cellular in-growth and exposes bone-forming proteins to the healing environment; OsteoSponge SC that fills bony defects in the subchondral region of joints; OsteoSelect DBM Putty for osteoinductive bone growth; OsteoSelect PLUS DBM Putty for use as a bone void filler a...
Financial Performance
In 2020, XTNT's revenue was $53.34 million, a decrease of -17.54% compared to the previous year's $64.68 million. Losses were -$7.02 million, -14.57% less than in 2019.
Financial StatementsAnalyst Forecast
According to one analyst, the rating for XTNT stock is "Hold" and the 12-month stock price forecast is 1.00.
News
Xtant Medical Announces Second Quarter 2021 Financial Results
BELGRADE, Mont., Aug. 05, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disor...
Xtant Medical to Present at the Canaccord Musculoskeletal Conference
BELGRADE, Mont., May 13, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disord...
Xtant Medical Announces First Quarter 2021 Financial Results
BELGRADE, Mont., May 11, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disord...
Xtant Medical Files $150 Million Shelf Registration Statement
BELGRADE, Mont., May 11, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disord...
Xtant Medical Announces $20 Million Debt Financing with MidCap Financial
BELGRADE, Mont., May 06, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disord...
Xtant Medical to Issue First Quarter 2021 Financial Results on May 11, 2021
BELGRADE, Mont., May 04, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disord...
Xtant Medical Comments on Trading Activity of its Stock
BELGRADE, Mont., Feb. 26, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT, the “Company”), a global medical technology company focused on surgical solutions for the treatment ...
XTNT Stock: 7 Things to Know About Xtant Medical as Shares Rocket 150%
Xtant Medical (XTNT) stock is surging higher Friday and InvestorPlace has everything potential investors need to know about the company. The post XTNT Stock: 7 Things to Know About Xtant Medical as Shar...
Xtant Medical Announces Fourth Quarter and Full Year 2020 Financial Results
BELGRADE, Mont., Feb. 24, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disor...
Xtant Medical Announces $20 Million Private Placement
BELGRADE, Mont., Feb. 22, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT) (the Company), a global medical technology company focused on surgical solutions for the treatment o...
Xtant Medical to Issue Fourth Quarter and Full Year 2020 Financial Results and Host Conference Call on February 24, 2021
BELGRADE, Mont., Feb. 17, 2021 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disor...
Xtant Medical Announces Expiration of Rights Offering
BELGRADE, Mont., Dec. 07, 2020 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disor...
Xtant Medical Holdings, Inc. (XTNT) CEO Sean Browne on Q3 2020 Results - Earnings Call Transcript
Xtant Medical Holdings, Inc. (XTNT) CEO Sean Browne on Q3 2020 Results - Earnings Call Transcript
Xtant Medical Announces Third Quarter 2020 Financial Results
BELGRADE, Mont., Oct. 29, 2020 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disor...
Xtant Medical Announces Record Date and Other Key Dates for Proposed $15 Million Rights Offering
BELGRADE, Mont., Oct. 22, 2020 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disor...
Xtant Medical to Issue Third Quarter 2020 Financial Results on October 29, 2020
BELGRADE, Mont., Oct. 20, 2020 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disor...
Xtant Medical Regains Compliance with NYSE American Continued Listing Standards
BELGRADE, Mont., Oct. 06, 2020 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disor...
XTNT Stock Skyrockets After Xtant Medical Holdings Restructures Debt
Xtant Medical Holdings news on Friday has XTNT stock skyrocketing after the company announced the completion of their debt restructuring plan. The post XTNT Stock Skyrockets After Xtant Medical Holdings...
Xtant Medical Announces Closing of Debt Restructuring
BELGRADE, Mont., Oct. 01, 2020 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal disor...
Xtant Medical Announces U.S. Commercial Launch of the Matriform® Si for Spinal Fusion Procedures
BELGRADE, Mont., Aug. 24, 2020 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal dis...
Kaskela Law LLC Announces Investigation of Xtant Medical Holdings, Inc. (XTNT) and Encourages XTNT Stockholders to Co...
PHILADELPHIA, Aug. 15, 2020 /PRNewswire/ -- Kaskela Law LLC announces that it is investigating Xtant Medical Holdings, Inc.
Xtant Medical Announces Debt Restructuring
BELGRADE, Mont., Aug. 10, 2020 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal dis...
Xtant Medical Holdings, Inc. (XTNT) CEO Sean Browne on Q2 2020 Results - Earnings Call Transcript
Xtant Medical Holdings, Inc. (XTNT) CEO Sean Browne on Q2 2020 Results - Earnings Call Transcript
Xtant Medical Announces Second Quarter 2020 Financial Results
BELGRADE, Mont., Aug. 03, 2020 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal dis...
Xtant Medical to Issue Second Quarter 2020 Financial Results on August 3, 2020
BELGRADE, Mont., July 30, 2020 (GLOBE NEWSWIRE) -- Xtant Medical Holdings, Inc. (NYSE American: XTNT), a global medical technology company focused on surgical solutions for the treatment of spinal dis...